Holds one active US DMF and one valid CEP for ketorolac tromethamine, filing since 1999. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and one valid CEP for ketorolac tromethamine, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.
Holds 2 active US DMFs and one valid CEP for ketorolac tromethamine, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for ketorolac tromethamine, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for ketorolac tromethamine, filing since 2025. Its 2018 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
This page filters the worldwide Ketorolac Tromethamine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for ketorolac tromethamine and what filings they hold.
Chat with Fred, your AI analyst